- Previous Close
1.0100 - Open
1.0000 - Bid 1.0300 x 100
- Ask 1.0500 x 100
- Day's Range
1.0000 - 1.0500 - 52 Week Range
0.9600 - 2.3700 - Volume
107,088 - Avg. Volume
885,916 - Market Cap (intraday)
140.816M - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3400 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
www.organigram.ca1,093
Full Time Employees
September 30
Fiscal Year Ends
Sector
Recent News: OGI
View More
Performance Overview: OGI
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OGI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OGI
View MoreValuation Measures
Market Cap
137.42M
Enterprise Value
111.66M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.90
Price/Book (mrq)
0.60
Enterprise Value/Revenue
0.96
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-31.69%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
166.12M
Net Income Avi to Common (ttm)
-52.65M
Diluted EPS (ttm)
-0.3400
Balance Sheet and Cash Flow
Total Cash (mrq)
46.8M
Total Debt/Equity (mrq)
2.77%
Levered Free Cash Flow (ttm)
--